$56.79
3.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 11
Data gathered: December 11
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | N/A | N/A |
| Sentiment | N/A | N/A |
| Webpage traffic | N/A | N/A |
| Employee Rating | N/A | N/A |
| Google Trends | N/A | N/A |
| Linkedin Employees | N/A | N/A |
| Patents | N/A | N/A |
| 4chan Mentions | N/A | N/A |
| Facebook Engagement | N/A | N/A |
| Facebook followers | N/A | N/A |
| Stocktwits Mentions | N/A | N/A |
| Stocktwits Subscribers | N/A | N/A |
| Twitter Followers | N/A | N/A |
| Youtube Subscribers | N/A | N/A |
| News Mentions | N/A | N/A |
| Reddit Mentions | N/A | N/A |
| Business outlook | N/A | N/A |
In the news
 |
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host DiseaseDecember 10 - Yahoo |
 |
Wall Street Breakfast: The Week AheadDecember 9 - SeekingAlpha |
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition ProgramDecember 8 - GlobeNewswire |
|
 |
Incyte Corp. stock underperforms Friday when compared to competitorsDecember 8 - MarketWatch |
Catalyst Watch: Intel's AI event, Oracle earnings and CAVA IPO lockup expirationDecember 7 - Seeking Alpha |
|
|
Incyte Corp. stock underperforms Thursday when compared to competitorsDecember 7 - MarketWatch |
About Incyte
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally.
| Price | $56.79 |
| Target Price | Sign up |
| Market Cap | $12.3B |
| Dividend Yield | 0.0059 |
| Industry | Biotechnology |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 918M | 60M | 858M | 171M | 261M |
| Q2 '23 | 954M | 68M | 886M | 204M | 265M |
| Q1 '23 | 808M | 57M | 751M | 22M | 64M |
| Q4 '22 | 929M | 59M | 870M | 28M | 121M |
| Q3 '22 | 823M | 55M | 768M | 113M | 145M |
Insider Transactions
| SWAIN PAULA J filed to sell 77,530 shares at $65.1. September 6 '23 |
| Stein Steven H filed to sell 97,583 shares at $63.3. August 3 '23 |
| Pasquale Maria E filed to sell 68,524 shares at $84.1. February 2 '23 |
| Pasquale Maria E filed to sell 68,524 shares at $84.7. February 1 '23 |
| Dhanak Dashyant filed to sell 53,263 shares at $85. January 30 '23 |
Read more about Incyte and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, reddit mentions, business outlook.